Sensitive ASX Announcement

Dose Escalation Approved in ACCENT Clinical Trial of AMP945

Published: 11/01/23, 01:50pm (AEST)2 pages
Amplia Therapeutics Limited
ATX:ASXHealthcare

Recent ATX Announcements

Price Sensitive only